WEScover: selection between clinical whole exome sequencing and gene panel testing

BACKGROUND: Whole exome sequencing (WES) is widely adopted in clinical and research settings; however, one of the practical concerns is the potential false negatives due to incomplete breadth and depth of coverage for several exons in clinically implicated genes. In some cases, a targeted gene panel...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, In-Hee, Lin, Yufei, Alvarez, William Jefferson, Hernandez-Ferrer, Carles, Mandl, Kenneth D., Kong, Sek Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Software
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139020/
https://www.ncbi.nlm.nih.gov/pubmed/34016036
http://dx.doi.org/10.1186/s12859-021-04178-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139020/
https://www.ncbi.nlm.nih.gov/pubmed/34016036
http://dx.doi.org/10.1186/s12859-021-04178-5

Ejemplares similares